SenzaGen is present at the Medical Design & Manufacturing (MD&M) Minneapolis The MD&M Minneapolis Conference is the region's largest educational offering of its kind, taking place in North America's second […]
SenzaGen is participating at The American College of Toxicology 2018 Annual Meeting that will be held Nov. 4-7 in West Palm Beach. This year’s meeting will feature lectures, poster sessions, and other […]
24th annual conference
SenzaGen is participating at the Biocompatibility for Medical Devices, Barcelona. Updates and changes to the ISO 10993 standards, regulatory updates and case studies of how to use ISO 10993 for evaluation […]
En 2018, le congrès annuel de la SFT a lieu à Lille, les 27 et 28 novembre, espace Jeanne de Flandre (Lille Grand Palais). Poster GARD® – in vitro safety […]
Dr Andy Forreryd is one of three speakers at the Human Safety Seminar organised by Eurofins BioPharma Product Testing Munich where he is to present the GARD platform for skin and respiratory sensitization Topics for […]
In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasions, this one targeted for the EUROPEAN time zone […]
In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasion. This one targeted forthe US audience at 13:00 […]
SenzaGen is participating at The Society of Toxicology of Canada 50th Annual Symposium, Winter 2018 WHAT’S IN A NAM ? (NOVEL APPROACH METHODOLOGIES). BENEFITS, LIMITATIONS, TRANSLATION, COMMUNICATION. | DECEMBER 10 […]
SenzaGen is attending the Training and Knowledge-sharing Workshop - "Applying non-animal strategies for assessing skin sensitization" in Helsinki, Finland. The main objective of the workshop is to discuss how the information […]
